Frontlight ResearchEarly access
What researchers published on Ankylosing spondylitis
5,616 papers, newest first.
Showing 20 of 242
Trial resultDetecting the TNF-α -308G/A Polymorphism by Quantitative PCR and its Correlation with Therapeutic Efficacy in Ankylosing Spondylitis.Clinical laboratory
In plain wordsRead moreRead the paper on PubMedRandomised trialFocused Extracorporeal Shock Wave Therapy Versus Therapeutic Ultrasound as Adjuncts to Exercise-Based Rehabilitation for Functional Limitation in Ankylosing Spondylitis: An Assessor-Blinded Randomized Comparative Trial.Musculoskeletal care
In plain wordsRead moreRead the paper on PubMedTrial result¹⁸F-sodium fluoride PET/CT as a complementary measure of osteoblastic disease burden in axial spondyloarthritis: a prospective exploratory study.European journal of nuclear medicine and molecular imaging
In plain wordsRead moreRead the paper on PubMedRandomised trialComparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
In plain wordsRead moreRead the paper on PubMedRandomised trialBimekizumab efficacy in male and female patients with axial spondyloarthritis: 52-week results from the phase 3 BE MOBILE trials.Rheumatology (Oxford, England)
In plain wordsRead moreRead the paper on PubMedRandomised trialIvarmacitinib in patients with active ankylosing spondylitis: subgroup analysis based on key baseline features from a phase II/III trial.Clinical rheumatology
In plain wordsRead moreRead the paper on PubMedRandomised trialEarly divergence of treatment response trajectories to adalimumab or its biosimilar in active ankylosing spondylitis: consensus clustering analysis of a randomized controlled trial.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedRandomised trialEffect of Bimekizumab Treatment on Health Status, Work Productivity, and Productivity Costs Through 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis.The Journal of rheumatology
In plain wordsRead moreRead the paper on PubMedRandomised trialComparison of the established ASAS definition and preliminary proposed data-driven cut-offs for inflammatory and structural MRI lesions in the sacroiliac joints for eligibility of patients with nonradiographic axial spondyloarthritis in clinical trials.Annals of the rheumatic diseases
In plain wordsRead moreRead the paper on PubMedRandomised trialBimekizumab Long-Term Safety and Efficacy Across the Spectrum of Axial Spondyloarthritis Over 3 Years: Results From 2 Phase III Studies.The Journal of rheumatology
In plain wordsRead moreRead the paper on PubMedRandomised trialEnhancing spinal mobility and functional capacity through aerobic exercise and yoga in ankylosing spondylitis: a randomized controlled trial.Rheumatology international
In plain wordsRead moreRead the paper on PubMedRandomised trialCost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trial.Rheumatology international
In plain wordsRead moreRead the paper on PubMedTrial resultElectroacupuncture for the relief of suboptimally managed pain in ankylosing spondylitis: A single-arm pilot study.Acupuncture in medicine : journal of the British Medical Acupuncture Society
In plain wordsRead moreRead the paper on PubMedRandomised trialPhase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitis.RMD open
In plain wordsRead moreRead the paper on PubMedRandomised trialBimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extension.RMD open
In plain wordsRead moreRead the paper on PubMedRandomised trialVunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial.JAMA network open
In plain wordsRead moreRead the paper on PubMedRandomised trial[First approved rheumatological digital health application for axial spondyloarthritis].Zeitschrift fur Rheumatologie
In plain wordsRead moreRead the paper on PubMedRandomised trialNo major effect of age (< 40 vs. ≥ 40 years) on response to secukinumab in patients with axSpA: a post hoc analysis of six phase 3 trials.Arthritis research & therapy
In plain wordsRead moreRead the paper on PubMedTrial resultRemote personalised exercise in axial spondyloarthritis: the SPARK trial - protocol for a 6-month randomised controlled trial.BMJ open
Randomised trialBalloon-assisted eggshell procedure via pedicle subtraction osteotomy for thoracolumbar kyphosis in ankylosing spondylitis: A randomized controlled trial.Journal of orthopaedic surgery (Hong Kong)
In plain wordsRead moreRead the paper on PubMed